Physician profile
Robert B Garrett
NPI 1548280688
$1,998.65
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,331 · 2020: $153 · 2021: $130 · 2022: $342 · 2023: $43.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $708.76 | 2019 | |
| Amgen INC. | $220.12 | 2019-2022 | |
| Boston Scientific Corporation | $176.20 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $171.67 | 2019-2022 | |
| Abbott Laboratories | $143.85 | 2019-2023 | Confirm Rx |
| W. L. Gore & Associates, INC. | $116.66 | 2019 | |
| Pfizer INC. | $89.33 | 2019-2022 | |
| Biosense Webster, INC. | $53.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.73 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.55 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.26 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.28 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.36 | 2019 | |
| Emd Serono, INC. | $24.41 | 2019 | |
| Merck Sharp & Dohme LLC | $17.76 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.32 | 2019 | |
| Esperion Therapeutics, INC. | $16.69 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.91 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.64 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.20 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $14.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.63 | 2020 | |
| Amarin Pharma, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.